Free Newsletter
Register for our Free Newsletters
Zones
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Materials
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
 
 
 
 
 
 
 
 
News

Cambio releases screening tools to accelerate drug discovery

Cambio : 12 April, 2012  (New Product)
Transcreener HTS Assays and iuvo Microconduit array technology is now exclusively available in the UK from Cambio to meet a demand for high performance tools which will speed discovery of new therapies.
Cambio releases screening tools to accelerate drug discovery
Dedicated to providing the pharmaceutical industry with more effective screening tools, BellBrook Labs developed the proprietary Transcreener assays, which use no radioactive compounds. The high throughput biochemical assay platform is now one of the most extensively validated methods for screening drug targets
such as protein kinases, as well as other nucleotide-dependent enzymes targeted for therapeutic intervention. Glycosyltransferase assays are available together with methyltransferase assays for investigators studying epigenetic regulation.

Cambio offers Transcreener ADP 2 , AMP/GMP, GDP and UDP Assays for direct detection of nucleotide enzyme products with far red, FI, FP and TR-FRET readouts.

These four HTS assays cover thousands of target enzymes, including any kinase, ATPase or GTPase. The Transcreener concept is based on single-step, homogenous fluorescence assays providing sensitive detection and proven performance.

Also available from Cambio, BellBrook’s iuvo Microconduit Arrays take a completely different approach: enabling the use of highly miniaturised, advanced cell models and functional assays which more accurately replicate in vivo processes.

The iuvo platform utilises surface tension effects inside different sized droplets. Liquid within a specially designed microchannel connecting two drops is replaced by liquid from the smaller drop through passive pumping - a phenomenon ideally suited to gentle washing of cells. This technology combines the
benefits of microfluidics with the advantages of normal pipetting techniques, simplifying work with primary cells, 3D matrices and co-culture, as well as reducing dilution of secreted signalling molecules. The microchannel environment within iuvo plates facilitates the use of automated liquid handling in addition to microscope-based HCA instruments and plate scanners.

The iuvo 3D Slide Device incorporates the 3D cellular assay capabilities of iuvo Microconduit Array plates into a lower throughput design that can be used with any inverted microscope. Applications include cell viability, cell motility and cell differentiation assays using immunocytostaining and live cell assay staining techniques.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com